Born from feedback received during meetings with our Corporate Partners in 2022, the IASLC Partners for Thoracic Cancer Care brings IASLC leadership and Roundtable Member Representatives together to collaborate on solutions to big-picture challenges facing those working to conquer lung cancer and other thoracic malignancies.
The Partners for Thoracic Cancer Care will focus on educational, scientific, and pilot projects (i.e., biomarker and NGS testing, lung cancer screening, targeted therapies, diversifying clinical trials, addressing health inequities, etc.) that lead to actionable and implementable measures for community physicians to improve patient outcomes for lung cancer and other thoracic malignancies. Following completion of the initial projects, the next project(s)/action(s) will be determined by consensus (2/3 approval) of the members of the Partners for Thoracic Cancer Care. IASLC retains the right to veto any proposed projects that fall outside the scope of IASLC’s mission and strategic plan.
Depending on the focus of a specific meeting, IASLC Partner Representatives may vary at the discretion of each organization, depending on the expertise required for that meeting. There is no limit on the number of consecutive terms one individual may serve.
Contact Matt Yeingst with any questions at matt.yeingst@iaslc.org